All News
New ACR RA Guidelines and Practice Changing Abstracts: RA Panel
Dr. Jonathan Kay leads an international panel discussion on the new ACR RA guidelines and several practice-changing abstracts presented at the 2020 ACR meeting. Panelists include Dr. Kathryn Dao, Dr. Eric Dein, Dr. Meral El Ramahi, Dr. Richard Conway and Dr. Sheila Reyes.
Read Article
New ACR RA Guidelines and Practice Changing Abstracts #ACR20
https://t.co/3lGSUDks8F
Links:
Dr. John Cush RheumNow ( View Tweet)
Check this out!
Can PT-CDAI in Telemedicine be Used for Care in RA? Dr. Eric Dein ( @ejdein1) #ACR20
https://t.co/dAgYOFMMJC https://t.co/QV02h171yP
Links:
Dr. John Cush RheumNow ( View Tweet)
"Erosions on X-ray: can we delegate this to the computers?" by Dr. David Liew ( @drdavidliew) #ACR20
https://t.co/YvKjAWebT9 https://t.co/RS4P29UVym
Links:
Dr. John Cush RheumNow ( View Tweet)
Rheumatoid Arthritis and ILD: Dr. Janet Pope ( @Janetbirdope) interviews Dr. Jeffrey Sparks ( @jeffsparks) about abstracts #0392, #0491, #1198 and #0489 presented at #ACR20.
https://t.co/e6HI1SqqSf https://t.co/naXAo8nc1g
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACRO20Tweets
"RT @RHEUMarampa : Large cohort of older RA pts newly rx w/HCQ or MTX:
👉~2-fold ⬆ risk of VTE – both PE and DVT- among patients newly treated with MTX vs. HCQ.
@RheumNow #ACR20 abs#2000 @DanielHSolomon https://t.co/4gK7hwdhIr" https://t.co/JsGBFrp7Hl
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @ejdein1 : Worth checking out the #ACR20 image competition. Here's an image of cerebral toxoplasmosis during ADA treatment for RA https://t.co/JH07pMjvRe https://t.co/H9LHwiw4xL
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @DrMiniDey : Late breaking: in older #rheumatoidarthritis patients, those taking MTX have 2x risk of #VTE compared to those on HCQ. Important to consider #thromboembolic risk factors when starting new RA treatment.
Abs#2000 #ACR20
https://t.co/lMYlXgaHyE https://t.co/0Fdone9yb3
Links:
Dr. John Cush RheumNow ( View Tweet)
Watch this three minute video on Subclinical Synovitis with Dr Eric Dein ( @ejdein1) #ACR20
https://t.co/rGqgseyWBv https://t.co/6snzAjbuaU
Links:
Dr. John Cush RheumNow ( View Tweet)
Significance of ANA+ in Managing RA with Dr Eric Dein ( @ejdein1) #ACR20
https://t.co/LdRaPNyJgq https://t.co/yuPq49hoLq
Links:
Dr. John Cush RheumNow ( View Tweet)
Have five minutes to spare? Check out this video titled, "HCQ and QTc in RA and SLE Patient" with Dr. Kathryn Dao ( @KDAO2011). #ACR20
https://t.co/EY6LPX25Bn https://t.co/wRM61hMelo
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @RichardPAConway Dr Lillegraven presents a randomized open-label phase 4, non-Inferiority trial of TNFi tapering in RA patients in sustained remission. 63% of tapered patients flared over 12 months vs 5% of maintained. https://t.co/JwR86kJf56 https://t.co/fFRVf6TYf9
Links:
Dr. John Cush RheumNow ( View Tweet)
Check out this quick video on lifestyle, clinical risk factors for RA-ILD with Dr. Sheila Reyes (@RHEUMarampa) #ACR20
https://t.co/7LQ7RCtiuj https://t.co/CjjtUauy2u
Links:
Dr. John Cush RheumNow ( View Tweet)
XRay Bone Erosions in CCP+ Patients with Dr Eric Dein ( @ejdein1) #ACR20
https://t.co/f6RnoExBgk https://t.co/MJCp3sR1UZ
Links:
Dr. John Cush RheumNow ( View Tweet)
Check out this video on combo therapy v monotherapy (SEAM-RA Trial) with Dr. Richard Conway (@RichardPAConway). #ACR20
https://t.co/iNsmKHSnMq https://t.co/tELmueVEK0
Links:
Dr. John Cush RheumNow ( View Tweet)
What is the SEAMless transition from combination Etanercept to Methotrexate? Dr. Jonathan Kay takes a deep dive into plenary abstract #0939 presented at #ACR20 annual meeting, reviewing two previous clinical trials that also looked at this question.
https://t.co/58raeaE8Mr https://t.co/ZP2P0IZ1Fc
Links:
Dr. John Cush RheumNow ( View Tweet)
View one of our fantastic #ACR20 video titled "Staying on Therapy in RA" with Dr. Janet Pope ( @Janetbirdope)
https://t.co/imCpxVs2N8 https://t.co/AcTBGaapig
Links:
Dr. John Cush RheumNow ( View Tweet)
What is the SEAMless transition from combination Etanercept to Methotrexate? with Dr. Jonathan Kay #ACR20
https://t.co/58raeaE8Mr https://t.co/FUIidcoy4I
Links:
Dr. John Cush RheumNow ( View Tweet)
Improving Drug Adherence in RA: Dr Janet Pope ( @Janetbirdope) Reviews abstract #799 presented at #ACR20.
https://t.co/ONCJmCOdzC https://t.co/ornpQiopTS
Links:
Dr. John Cush RheumNow ( View Tweet)
SEAM-RA Trial: Dr. Jeff Curtis ( @RADoctor) discusses abstract # 0939 that looked at whether RA patients at or close to remission should continue taking their combination therapy, as presented at #ACR20
https://t.co/2yMyj4BKs1 https://t.co/2gqJM4EKpG
Links:
Dr. John Cush RheumNow ( View Tweet)
